EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Minimizing Vaccine Wastage in Nigeria: A National Assessment of Vaccine Wastage Rates and Potential Determinants

Kikelomo Lambo, Martha Prescott, Owens Wiwa, Jude Adebowale, Kubura Daradara

Vaccines · 08.08.2024 · 12 (8) · 900

DOI: 10.3390/vaccines12080900 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vaccines, online erschienen am 08.08.2024. Verfasst von Kikelomo Lambo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Clinton Health Access Initiative (CHAI), 7 Ganges Street Off Alvan Ikoku Way, Abuja 900271, Nigeria. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gavi, Gavi, the Vaccine Alliance.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High vaccine wastage can serve as a critical barrier to achieving the gains of vaccination, especially in a country like Nigeria, where data on vaccine wastage are sparsely available. We determined the country-wide vaccine wastage rates and their determinants through a mixed-methods study conducted across 576 health facilities (primary and secondary) in 24 states in Nigeria. We collected facility-based immunization records from June 2018 to May 2019, in addition to healthcare workers’ interviews and observations of fixed and outreach sessions. The results show that open-vial wastage ranged from 21.2% (95% CI: 20.2%, 22.2%) for the pentavalent vaccine to 72.6% (95% CI: 71.5%, 73.6%) for BCG. Open-vial wastage rates for BCG, measles, and yellow fever vaccines were higher during outreach sessions, with rates of 76.2%, 64.3%, and 65.2%, respectively. For the outreach and fixed sessions, PCV and Penta had the least wastages of 22.0% for fixed sessions and 20.4% for outreach sessions. This study identified vaccine presentation (liquid vs. lyophilized vaccines), vial size (4 dose vs. 5 dose vs. 10 dose vs. 20 dose), RI service delivery strategies (fixed vs. outreach sessions), number of children vaccinated, and human resources (healthcare workers position/cadre) as key determinants of vaccine wastages in Nigeria.

Schlagwörter

Stichwörter der Autor:innen

Nigeriaopen vialvaccineswastagewastage rate

Autor:innen und Institutionen

  • Clinton Health Access Initiative (CHAI), 7 Ganges Street Off Alvan Ikoku Way, Abuja 900271, Nigeria.
  • Clinton Health Access Initiative (CHAI), 383 Dorchester Ave, Suite 400, Boston, MA 02127, USA.
  • National Primary Health Care Development Agency (NPHCDA), Abuja 900103, Nigeria.

Förderung

  • Gavi
  • Gavi, the Vaccine Alliance

Zitieren

APA

Lambo, K., Prescott, M., Wiwa, O., Adebowale, J., & Daradara, K. (2024). Minimizing Vaccine Wastage in Nigeria: A National Assessment of Vaccine Wastage Rates and Potential Determinants. Vaccines, 12(8), 900. https://doi.org/10.3390/vaccines12080900

Vancouver

Lambo K, Prescott M, Wiwa O, Adebowale J, Daradara K. Minimizing Vaccine Wastage in Nigeria: A National Assessment of Vaccine Wastage Rates and Potential Determinants. Vaccines. 2024;12(8):900. doi:10.3390/vaccines12080900

BibTeX
@article{Lambo2024,
  author = {Lambo, Kikelomo and Prescott, Martha and Wiwa, Owens and Adebowale, Jude and Daradara, Kubura},
  title = {Minimizing Vaccine Wastage in Nigeria: A National Assessment of Vaccine Wastage Rates and Potential Determinants},
  journal = {Vaccines},
  year = {2024},
  volume = {12},
  number = {8},
  pages = {900},
  doi = {10.3390/vaccines12080900}
}
Kostenlos starten →